Experimental study demonstrates versatile synthesis of cyclotriphosphazene-based glycodendrimers, indicating potent inhibition of biomedically relevant lectins.
The cyclotriphosphazene-based platform facilitates versatile synthesis of glycodendrimers active as inhibitors of two biomedically relevant lectins.
No takes yet. Share an insight, caveat, or question.
Abbassi et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: